Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Drugs alphabetical "v", total number of products: 434
Reg.‑No.
Product
Composition
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
|
0-9
1 - 100
101 - 200
201 - 300
301 - 400
401 - 434
60326
IP
CI
Votrient 200 mg
Coated tablets: Pazopanibum 200 mg
G
60326
IP
CI
Votrient 400 mg
Coated tablets: Pazopanibum 400 mg
G
62812
IP
CI
Votubia 2 mg
Dispersible Tablets: Everolimusum 2 mg
G
62061
IP
CI
Votubia 2.5 mg
Tablets: Everolimusum 2.5 mg
G
62812
IP
CI
Votubia 3 mg
Dispersible Tablets: Everolimusum 3 mg
G
62061
IP
CI
Votubia 5 mg
Tablets: Everolimusum 5 mg
G
57142
IP
CI
Votum 10 mg
Coated tablets: Olmesartanum Medoxomilum 10 mg
G
57142
IP
CI
Votum 20 mg
Coated tablets: Olmesartanum Medoxomilum 20 mg
G
57142
IP
CI
Votum 40 mg
Coated tablets: Olmesartanum Medoxomilum 40 mg
G
57554
IP
CI
Votum plus 20/12.5
Coated tablets: 2 Active Agents
G
57554
IP
CI
Votum plus 20/25
Coated tablets: 2 Active Agents
G
57554
IP
CI
Votum plus 40/12.5
Coated tablets: 2 Active Agents
G
57554
IP
CI
Votum plus 40/25
Coated tablets: 2 Active Agents
G
69569
IP
CI
Voxzogo 0.4 mg
Lyophilisate and solvent: Vosoritidum
G
69569
IP
CI
Voxzogo 0.56 mg
Lyophilisate and solvent: Vosoritidum
G
69569
IP
CI
Voxzogo 1.2 mg
Lyophilisate and solvent: Vosoritidum 1.2 mg
G
69301
IP
CI
Voydeya 100 mg
Coated tablets: Danicopanum 100 mg
G
69301
IP
CI
Voydeya 50 mg / 100 mg
Coated tablets: Danicopanum 50 mg
Coated tablets: Danicopanum 100 mg
G
61297
IP
CI
VPRIV 400 U
Lyophilisate: Velaglucerasum Alfa 400 U
G
66314
IP
CI
Vroni Gynial
überzogene Tablette: 2 Active Agents
G
69761
IP
Vueway
G
69760
IP
Vueway
G
68066
IP
CI
Vumerity 231 mg
Gastric-juice-resistant Capsules: Diroximeli Fumaras 231 mg
G
69035
IP
CI
Vydura 75 mg
Soluble Powder: Rimegepantum 75 mg
G
67995
IP
Vyepti 100 mg/1 ml
Concentrate for infusion: Eptinezumabum 100 mg/ml
G
67995
IP
Vyepti 300 mg/3 ml
Concentrate for infusion: Eptinezumabum 300mg / 3ml
G
69501
IP
Vyloy 100 mg
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Zolbetuximabum 100 mg
G
69501
IP
Vyloy 300 mg
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Zolbetuximabum 300 mg
G
67083
IP
CI
Vyndaqel 20 mg
Soft capsules: Tafamidisum Megluminum 20 mg
G
67518
IP
CI
Vyndaqel 61 mg
Soft capsules: Tafamidisum 61 mg
G
70518
IP
Vyvgart 1000 mg/ 5 ml
solution injectable en seringue préremplie: Efgartigimodum Alfa 1000mg / 5ml
G
69725
IP
Vyvgart 1000 mg/ 5.6 ml
Injection solution: Efgartigimodum Alfa 1000mg / 5.6ml
G
69286
IP
Vyvgart 400 mg/20ml
Concentrate for infusion: Efgartigimodum Alfa 400mg / 20ml
G
68014
IP
Vyxeos liposomal 44 mg/100 mg
Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion: 2 Active Agents
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home